Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin®
Source: eagletribune.com
Stay updated with breaking news from Robert Mulroy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin®
/PRNewswire/ -- Partner Therapeutics, Inc. (PTx) announced that its partner Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device...
MACK | Complete Merrimack Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.